Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 MNNGF | Consumer Cyclical | $0.15 | 0.00 | $191.93M | -28.88 | ― | ― |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| MNNGF | Affluent Partners Holdings | 0.15 | 0.07 | 87.50% |
| Name | Price | % Change | |
|---|---|---|---|
| MNNGF | $0.15 | +87.50% |
Affluent Partners Holdings ( ($HK:1466) ) just unveiled an update. Shareholders of Baijin Life Science Holdings Limited unanimously approved all resolutions at the annual general meeting held on 16 September
The latest update is out from Affluent Partners Holdings ( ($HK:1466) ). Baijin Life Science Holdings has convened its 2026 annual general meeting for mid-September in Hong Kong, where shareholders
An update from Affluent Partners Holdings ( ($HK:1466) ) is now available. Baijin Life Science Holdings reported a sharp decline in revenue to HK$89.3 million for the year ended 31
Affluent Partners Holdings ( ($HK:1466) ) has issued an update. Baijin Life Science Holdings has issued a profit warning, indicating it expects to post a loss of not more than
The latest announcement is out from Affluent Partners Holdings ( ($HK:1466) ). Baijin Life Science Holdings has disclosed an update on director information after a Hong Kong court ordered the
Affluent Partners Holdings ( ($HK:1466) ) just unveiled an update. Baijin Life Science Holdings has scheduled a board meeting for 30 June 2026 to approve the annual results for the
Affluent Partners Holdings ( ($HK:1466) ) has provided an update. Baijin Life Science Holdings has announced that its subsidiary Beijing Baijin Biotechnology has signed a strategic cooperation framework agreement with
The latest announcement is out from Affluent Partners Holdings ( ($HK:1466) ). Baijin Life Science Holdings has granted 67,925,226 share options under its 2024 Share Option Scheme to directors, independent
Affluent Partners Holdings ( ($HK:1466) ) has shared an update. Baijin Life Science Holdings has appointed Ms. Shen Ding as an independent non‑executive director and member of its audit, remuneration
An announcement from Affluent Partners Holdings ( ($HK:1466) ) is now available. Baijin Life Science Holdings has released an updated list of its directors and clarified the composition of its
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| MNNGF | Nov 26, 2026TBA | $191.93M | ― | ― | -0.00 | -28.88 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
